OSTEONIC acquires controlling stake in FoxEyes for 3 billion won
OSTEONIC acquired a 51% stake in FoxEyes, a U.S.-based developer of spinal surgery robots, for approximately 3 billion won, with plans for additional investments totaling 10 billion won by 2028.
